Search
for
Sort by
Research 121–150 of 313
- Do Alpha-Blockers and 5-Alpha Reductase Inhibitors Increase Dementia Risk? A Network Meta-analysis
- 61537 No Increased Risk of Breast or Gynecologic Cancers in Women with 5α-Reductase Inhibitor Exposure for Female Pattern Hair Loss: A Population-Based Propensity Score-Matched Cohort Study
- Abstracts from the 2024 WDS Forum - virtual option
- Impact of finasteride and dutasteride in beard thickness in men with androgenetic alopecia: a 453-patient retrospective trial
- MP31-04 HOW DO 5-ALPHA-REDUCTASE INHIBITORS CHANGE PSA DENSITY IN PATIENTS ON ACTIVE SURVEILLANCE?
- Evaluating 5 alpha reductase inhibitors for the treatment of male androgenic alopecia
- Use of 5-Alpha Reductase Inhibitors in Dermatology: A Narrative Review
- Litigation associated with 5-alpha-reductase-inhibitor use: A Canadian legal database review.
- MP44-04 TRENDS IN 5-ALPHA REDUCTASE INHIBITOR USE BEFORE AND AFTER THE FOOD AND DRUG ADMINISTRATION SAFETY WARNING
- Treatment of Alopecia with New Approaches: An Updated Review
- Effect of 5-alpha reductase inhibitors in animal models of Parkinson’s disease
- Risk of age-related macular degeneration in men receiving 5α-reductase inhibitors: a population-based cohort study
- Editor’s picks January 2021
- MP09-16 5-ALPHA REDUCTASE INHIBITORS FOR MALE LOWER URINARY TRACT SYMPTOMS: A COCHRANE SYSTEMATIC REVIEW AND META-ANALYSIS
- Comments concerning the real risk of sexual adverse events secondary to the use of 5-ARIs
- 5α‐Reductase Inhibitors
- PD23-06 CHANGE IN SEXUAL FUNCTION IN MEN WITH LUTS/BPH ASSOCIATED WITH LONG-TERM TREATMENT WITH DOXAZOSIN, FINASTERIDE, AND COMBINED THERAPY
- Major role for 5-alpha reductase inhibitors in the aging male
- Les Visiteurs des malades
- Urological Oncology: Prostate Cancer
- Dutasteride for Androgenetic Alopecia: Review Article
- 054 Post Finasteride Syndrome: Guess Who-Demographics from FDA Database
- Post-Finasteride Syndrome: An Underestimated Phenomenon
- 124 The Persistent Effects of 5α-reductase Inhibitors Used in the Treatment of Androgenic Alopecia on Men’s Health
- Adverse events with finasteride or dutasteride: FAERS
- Finasteride Inhibits Human Prostate Cancer Cell Invasion through MMP2 and MMP9 Downregulation
- Frontal fibrosing alopecia: An update on the hypothesis of pathogenesis and treatment
- The corpus cavernosum after treatment with dutasteride or finasteride: A histomorphometric study in a benign prostatic hyperplasia rodent model
- Non-surgical management of BPH: An updated review of current literature and state of the art on natural compounds and medical therapy
- Presence of Codes for Indication for Use in Clinical Practice Research Datalink Aurum: An Assessment of Benign Prostatic Hyperplasia Treatments